A new trading day began on Friday, with Leap Therapeutics Inc (NASDAQ: LPTX) stock price down -13.21% from the previous day of trading, before settling in for the closing price of $0.36. LPTX’s price has ranged from $0.36 to $4.79 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -20.00% over the past five years. Meanwhile, its annual earnings per share averaged 43.65%. With a float of $30.76 million, this company’s outstanding shares have now reached $38.33 million.
Let’s look at the performance matrix of the company that is accounted for 52 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Leap Therapeutics Inc (LPTX) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Leap Therapeutics Inc is 25.44%, while institutional ownership is 30.21%.
Leap Therapeutics Inc (LPTX) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.35 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 43.65% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 23.51% during the next five years compared to 34.28% growth over the previous five years of trading.
Leap Therapeutics Inc (NASDAQ: LPTX) Trading Performance Indicators
Here are Leap Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.41.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.84, a number that is poised to hit -0.39 in the next quarter and is forecasted to reach -0.70 in one year’s time.
Technical Analysis of Leap Therapeutics Inc (LPTX)
Leap Therapeutics Inc (NASDAQ: LPTX) saw its 5-day average volume 22.33 million, a positive change from its year-to-date volume of 2.64 million. As of the previous 9 days, the stock’s Stochastic %D was 9.89%. Additionally, its Average True Range was 0.07.
During the past 100 days, Leap Therapeutics Inc’s (LPTX) raw stochastic average was set at 0.32%, which indicates a significant decrease from 3.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 131.17% in the past 14 days, which was lower than the 213.91% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7291, while its 200-day Moving Average is $2.1933. Nevertheless, the first resistance level for the watch stands at $0.3421 in the near term. At $0.3675, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.3861. If the price goes on to break the first support level at $0.2981, it is likely to go to the next support level at $0.2795. The third support level lies at $0.2541 if the price breaches the second support level.
Leap Therapeutics Inc (NASDAQ: LPTX) Key Stats
With a market capitalization of 13.06 million, the company has a total of 41,258K Shares Outstanding. Currently, annual sales are 0 K while annual income is -81,410 K. The company’s previous quarter sales were 0 K while its latest quarter income was -18,180 K.
